BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9621172)

  • 1. [The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias].
    Maĭmeskulova LA; Maslov LN
    Eksp Klin Farmakol; 1998; 61(2):37-40. PubMed ID: 9621172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The anti-arrhythmia effect of Rhodiola rosea and its possible mechanism].
    Lishmanov IuB; Maslova LV; Maslov LN; Dan'shina EN
    Biull Eksp Biol Med; 1993 Aug; 116(8):175-6. PubMed ID: 7506072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea].
    Maĭmeskulova LA; Maslov LN; Lishmanov IuB; Krasnov EA
    Eksp Klin Farmakol; 1997; 60(1):38-9. PubMed ID: 9162281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The anti-arrhythmia properties of thymogen].
    Reznikov KM; Vinokurova OV; Alabovskiĭ VV; Vinokurov AA
    Eksp Klin Farmakol; 1994; 57(6):31-3. PubMed ID: 7756955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The anti-arrhythmic activity of agonists of the peripheral mu-opiate receptors].
    Maslov LN; Krylatov AV; Lishmanov IuB
    Eksp Klin Farmakol; 1999; 62(3):28-31. PubMed ID: 10439944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiarrhythmic activity of alaglyzin].
    Bryzgalov AO; Volkova EB; Ganenko IuA; Dolgikh MP; Zhukova NA; Sorokina IV; Tolstikova TG
    Eksp Klin Farmakol; 2005; 68(4):24-7. PubMed ID: 16193652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The antiarrhythmic action of the synthetic acetylcholine analog EDIHYP in calcium chloride- and strophanthin-induced heart rhythm disorders].
    Abdikaliev NA; Kalvin'sh IIa; Meerson FZ
    Farmakol Toksikol; 1991; 54(6):25-8. PubMed ID: 1804687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the antiarrhythmic activity of L-, D-and DL-stereoisomers of potassium magnesium aspartate].
    Spasov AA; Iezhitsa IN; Zhuravleva NV; Gurova NA; Sinolitskiĭ MK; Voronin SP
    Eksp Klin Farmakol; 2007; 70(1):17-21. PubMed ID: 17402586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardioprotective and antiarrhythmic properties of Rhodiolae roseae preparations].
    Maslov LN; Lishmanov IuB
    Eksp Klin Farmakol; 2007; 70(5):59-67. PubMed ID: 18074810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The mechanism of the anti-arrhythmia action of mu-opioid-receptor agonists in a model of CaCl2-induced arrhythmias: the role of the autonomic nervous system].
    Maslov LN; Lishmanov IuB; Krylatov AV; Ugdyzhekova DS
    Eksp Klin Farmakol; 1997; 60(1):35-7. PubMed ID: 9162280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiarrhythmic properties of the anticonvulsant drug benzonal].
    Saratikov AS; Fateeva SN; Forshkova VK
    Farmakol Toksikol; 1987; 50(6):42-4. PubMed ID: 3436422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The anti-arrhythmia activity of energy-providing and electron-acceptor compounds].
    Balashov VP; Balykova LA; Kostin IaV; Sernov LN
    Eksp Klin Farmakol; 1996; 59(2):17-9. PubMed ID: 8974556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of ecdysterone on experimental arrhythmias and changes in the hemodynamics and myocardial contractility induced by coronary artery occlusion].
    Kurmukov AG; Ermishina OA
    Farmakol Toksikol; 1991; 54(1):27-9. PubMed ID: 1860493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some aspects of the antiarrhythmic effect of glialin].
    Khisatmutdinova RIu; Baschenko NZh; Zarudiĭ FS; Gabdrakhmanova SF; Makara NS; Sapozhnikova TA
    Eksp Klin Farmakol; 2006; 69(3):26-8. PubMed ID: 16878494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The experimental anti-arrhythmia properties of the histamine H1 receptor blockader fencarol].
    Iakovlev GM; Skorobogatov VI; Svistov AS; Mironova MI
    Farmakol Toksikol; 1991; 54(5):25-7. PubMed ID: 1686869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Search for and study of antiarrhythmic substances among crown ethers].
    Luk'ianenko NG; Bogatskiĭ AV; Iaroshenko IM; Vongaĭ VG; Nazarov EI
    Farmakol Toksikol; 1984; 47(5):29-32. PubMed ID: 6238839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands].
    Lishmanov IuB; Maslov LN; Krylatov AV; Ugdyzhekova DS; Gilligan P; Tam SW
    Eksp Klin Farmakol; 2000; 63(2):39-43. PubMed ID: 10834092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].
    Berdiaev SU; Paliani-Katsitadze NSh; Turilova AI; Kaverina NV; Likhosherstov AM; Lebedeva AS; Ogurtsov VA
    Eksp Klin Farmakol; 1999; 62(4):26-9. PubMed ID: 10513331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The anti-arrhythmia activity of quinazopyrine].
    Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
    Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.